Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Director/PDMR Shareholding

17th Apr 2013 17:16

RNS Number : 6193C
GlaxoSmithKline PLC
17 April 2013
 



 Notification of Transactions of Directors, Persons Discharging

Managerial Responsibility or Connected Persons

 

 

The Administrators of the GlaxoSmithKline UK and US Performance Share Plans notified the Company and the under-mentioned persons on 17 April 2013 of the following increases in their notional interests in Ordinary Shares at a price of 1565.50 pence per Ordinary Share and American Depositary Shares (ADSs) at a price of $48.52 per ADS following the notional re-investment of the dividend paid to shareholders on 11 April 2013.

 

 

Ordinary Shares

ADSs

Sir Andrew Witty

14,975.978

Dr M M Slaoui

4,845.673

Mr S Dingemans

5,490.762

Mr S M Bicknell

1,624.186

Mr R G Connor

325.598

Mrs D P Connelly

2,058.731

Mr S A Hussain

4,136.092

Mr W C Louv

1,408.343

Mr D S Redfern

2,276.538

Ms C Thomas

3,143.972

Mr P C Thomson

800.315

Mr D E Troy

2,603.915

Dr P J T Vallance

4,589.736

Ms E Walmsley

2,596.317

Mr C Weber

488.564

Mrs V A Whyte

353.160

 

 

 

The notional dividends accrued will be paid out in proportion to the percentage of participants' Performance Share Plan holdings that vest following the end of the relevant three year measurement period.

 

This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).

 

 

V A Whyte

Company Secretary

 

17 April 2013

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSQDLFFXZFFBBZ

Related Shares:

Glaxosmithkline
FTSE 100 Latest
Value8,632.33
Change89.77